Correlation Between ANI Pharmaceuticals and Procaps Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and Procaps Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and Procaps Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANI Pharmaceuticals and Procaps Group SA, you can compare the effects of market volatilities on ANI Pharmaceuticals and Procaps Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of Procaps Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and Procaps Group.

Diversification Opportunities for ANI Pharmaceuticals and Procaps Group

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between ANI and Procaps is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and Procaps Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procaps Group SA and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with Procaps Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procaps Group SA has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and Procaps Group go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and Procaps Group

Given the investment horizon of 90 days ANI Pharmaceuticals is expected to generate 85.96 times less return on investment than Procaps Group. But when comparing it to its historical volatility, ANI Pharmaceuticals is 44.89 times less risky than Procaps Group. It trades about 0.05 of its potential returns per unit of risk. Procaps Group SA is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  62.00  in Procaps Group SA on August 24, 2024 and sell it today you would lose (60.90) from holding Procaps Group SA or give up 98.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy75.6%
ValuesDaily Returns

ANI Pharmaceuticals  vs.  Procaps Group SA

 Performance 
       Timeline  
ANI Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Procaps Group SA 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Procaps Group SA are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Procaps Group showed solid returns over the last few months and may actually be approaching a breakup point.

ANI Pharmaceuticals and Procaps Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ANI Pharmaceuticals and Procaps Group

The main advantage of trading using opposite ANI Pharmaceuticals and Procaps Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, Procaps Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procaps Group will offset losses from the drop in Procaps Group's long position.
The idea behind ANI Pharmaceuticals and Procaps Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Fundamental Analysis
View fundamental data based on most recent published financial statements
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges